3-[(1r,2r)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol monohydrochloride, (Tapentadol HCl) is the hydrochloride salt of Tapentadol, a centrally acting synthetic analgesic. Tapentadol Hydrochloride combines μ-opioid receptor agonist activity with norepinephrine reuptake inhibition, providing effective management of moderate to severe acute and chronic pain. The compound Tapentadol Hydrochloride is preferred and supplied as a white to off-white crystalline powder, offering good solubility in water and common pharmaceutical solvents. I dual mechanism of action makes it a unique option in pain therapy, with reduced gastrointestinal side effects compared to traditional opioids. It is a CNS agent (therapeutic class) as Phenolic compound (chemical structure).
3-[(1r,2r)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol monohydrochloride, (Tapentadol HCl) is the hydrochloride salt of Tapentadol, a centrally acting synthetic analgesic. Tapentadol Hydrochloride combines μ-opioid receptor agonist activity with norepinephrine reuptake inhibition, providing effective management of moderate to severe acute and chronic pain. The compound Tapentadol Hydrochloride is preferred and supplied as a white to off-white crystalline powder, offering good solubility in water and common pharmaceutical solvents. I dual mechanism of action makes it a unique option in pain therapy, with reduced gastrointestinal side effects compared to traditional opioids. It is a CNS agent (therapeutic class) as Phenolic compound (chemical structure).
.3d8f8f41.svg)
Pharmaceutical
.3556d45a.svg)
Pharmaceutical Actives & Precursors
Active Pharmaceutical Ingredients (APIs)
.7767eb0f.png&w=3840&q=75){kind=small}
Chemical Properties & Specifications
Not classified as hazardous under GHS (for intermediate handling)
P261: Avoid breathing dust. P280: Wear protective gloves and eye protection.
API in immediate-release and extended-release pain medications.
Used in large-scale production of CNS therapeutic agents.
Studies on neuropathic pain, post-surgical pain, and musculoskeletal disorders.
Comparative trials with other opioid and non-opioid analgesics.
Store at 15–25°C
Dry, well-ventilated areas
Store in tightly closed containers away from direct light
1 kg, 5 kg, 25 kg HDPE drums, with customized bulk packaging
